SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-019447
Filing Date
2020-07-16
Accepted
2020-07-16 20:22:14
Documents
2
Period of Report
2020-07-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5294
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4633
  Complete submission text file 0000899243-20-019447.txt   11445
Mailing Address C/O APPLIED GENETIC TECHNOLOGIES CORP. 11801 RESEARCH DRIVE, SUITE D ALACHUA FL 32615
Business Address
Carroll Jill (Reporting) CIK: 0001598542 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39381 | Film No.: 201032547

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Issuer) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations